Prenatal Opioid Exposure Changes Infant Amygdala Connectivity, RSNA Study Reports

Summary: Prenatal opioid exposure is linked to altered connections between the amygdala and other brain regions in newborns, according to new fMRI findings.

Source: RSNA

Overview

Opioid use during pregnancy presents a growing public health concern with serious implications for maternal and infant health. Infants exposed to opioids in utero frequently experience neonatal abstinence syndrome (NAS), a withdrawal condition that can require extended hospital stays, careful monitoring and, in severe cases, pharmacologic treatment. Beyond the immediate clinical challenges, there is increasing concern that prenatal opioid exposure may produce lasting changes in brain development that affect behavior and neurodevelopmental outcomes.

Study purpose

A multidisciplinary team led by Rupa Radhakrishnan, M.D., assistant professor of radiology and imaging sciences at Indiana University School of Medicine, set out to examine how prenatal opioid exposure alters early brain function. The researchers focused on the amygdala, a central brain region that processes and helps regulate emotions such as fear, sadness and aggression, and that plays a critical role in social and emotional development.

“There is limited data on how exposure to opioids before birth affects infants’ brains and what those early changes might mean for long‑term outcomes,” Dr. Radhakrishnan said. “By studying brain activity shortly after birth, we can better isolate the direct effects of opioid exposure on the developing brain and begin to understand how those changes may interact with social and environmental influences over time.”

Methods

The investigators studied 16 full‑term infants using resting‑state functional MRI (fMRI), a noninvasive technique that detects changes in blood flow to map brain activity and the functional connections between regions while the brain is at rest. The cohort included eight infants with documented prenatal opioid exposure and eight opioid‑naive infants without such exposure. All imaging—both anatomical MRI and resting‑state fMRI—was performed while the infants were naturally asleep to avoid sedation.

The team employed group independent component analysis to identify resting state networks and then applied regions of interest for the left and right amygdala to generate connectivity maps. This approach allowed the researchers to compare how the amygdala participated in functional networks across the two groups.

Key findings

The preliminary results revealed significant differences in amygdala connectivity between infants exposed to opioids before birth and opioid‑naive infants. Specifically, the pattern and strength of connections between the amygdala and several other brain regions differed in the exposed group, suggesting that prenatal opioid exposure may alter early functional brain organization involved in emotional processing and regulation.

“Our early results show meaningful differences in amygdala connectivity between the two groups,” Dr. Radhakrishnan said. “At this point, we cannot yet define the clinical implications of those differences, but the findings highlight a potential neural basis for later emotional, behavioral or developmental concerns that warrant further study.”

Implications and next steps

The investigators emphasize that this study is an early, small‑sample analysis and that larger, longitudinal studies are essential to validate and extend these findings. Ongoing research aims to follow children with prenatal opioid exposure over time to link early functional brain changes with later neurodevelopmental and behavioral outcomes, and to determine whether specific patterns of altered connectivity predict the severity or persistence of developmental challenges.

Understanding how prenatal opioid exposure affects brain networks could inform early identification strategies for infants at higher risk, guide management of NAS, and support development of interventions to improve long‑term outcomes. The research team stresses the importance of integrating neuroimaging data with clinical, social and environmental information so that patient care addresses the full range of factors influencing development.

Source:
RSNA
Media Contact:
Linda Brooks – RSNA
Image Source:
Image credit: study author and RSNA.

Original research presentation: The findings were presented at the 105th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) 2019. Larger and long‑term outcome studies are underway to better characterize the functional brain changes associated with prenatal opioid exposure and their relationship to developmental outcomes.